![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, January 31, 2023 12:45:30 PM
Research Scientist
About
I am a research scientist with Enzolytics Inc, a drug development company that focuses on multiple therapies for infectious diseases. I am leading the development of vaccines in the areas of infectious disease and chronic medical disease to create effective therapeutic monoclonal antibodies. My project focus on designing and developing next-generation monoclonal antibodies (mAbs) that represent one of the fastest-growing classes of protein therapeutics.
I have demonstrated expertise in understanding of immune system, preparing and optimizing protocols, identifying and troubleshooting experimental issues, and determining appropriate solutions.
I am an articulate team player, proficient in evaluating and analyzing validation data, verifying the adequacy of data, organizing and managing documents/reports, organizing and arranging large-scale experiments.
I possess in-depth knowledge and working understanding of immunoassays and molecular assays in BSL1 and BSL2 environments.
I orchestrate strong communication, critical thinking, and exceptional lab skills. Capable of leading research projects within strict time and budget constraints.
While others take pride in meeting all standards set before them, my passion is for delivering service that goes beyond organizational expectations, creating a win-win scenario for everyone involved!" Please feel free to contact me at alhaj2001@aggienetwork.com with any thoughts, comments, or questions about my work. I'm always interested in making new professional acquaintances.
Postdoctoral Researcher
Enzolytics Immunotherapeutics
May 2021 - Present1 year 9 months
College Station, TX, United States
https://www.linkedin.com/in/nasser-alhaj-ali-ph-d-90b07658
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM